JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schissel, S. L.
Right arrow Articles by Tabas, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schissel, S. L.
Right arrow Articles by Tabas, I.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 273, Issue 29, 18250-18259, July 17, 1998

The Cellular Trafficking and Zinc Dependence of Secretory and Lysosomal Sphingomyelinase, Two Products of the Acid Sphingomyelinase Gene

Scott L. SchisselDagger , George A. Keesler, Edward H. Schuchmanparallel , Kevin Jon Williams**, and Ira TabasDagger Dagger Dagger

From the Departments of Dagger  Anatomy & Cell Biology and Dagger Dagger  Medicine, Columbia University, New York, New York 10032,  Amgen, Boulder, Colorado 80301, the parallel  Department of Human Genetics, Mount Sinai School of Medicine, New York, New York 10029, and the ** Dorrance H. Hamilton Research Laboratories, Division of Endocrinology, Diabetes, and Metabolic Diseases, Thomas Jefferson University, Philadelphia, Pennsylvania 19107

The acid sphingomyelinase (ASM) gene, which has been implicated in ceramide-mediated cell signaling and atherogenesis, gives rise to both lysosomal SMase (L-SMase), which is reportedly cation-independent, and secretory SMase (S-SMase), which is fully or partially dependent on Zn2+ for enzymatic activity. Herein we present evidence for a model to explain how a single mRNA gives rise to two forms of SMase with different cellular trafficking and apparent differences in Zn2+ dependence. First, we show that both S-SMase and L-SMase, which contain several highly conserved zinc-binding motifs, are directly activated by zinc. In addition, SMase assayed from a lysosome-rich fraction of Chinese hamster ovary cells was found to be partially zinc-dependent, suggesting that intact lysosomes from these cells contain subsaturating levels of Zn2+. Analysis of Asn-linked oligosaccharides and of N-terminal amino acid sequence indicated that S-SMase arises by trafficking through the Golgi secretory pathway, not by cellular release of L-SMase during trafficking to lysosomes or after delivery to lysosomes. Most importantly, when Zn2+-dependent S-SMase was incubated with SMase-negative cells, the enzyme was internalized, trafficked to lysosomes, and became zinc-independent. We conclude that L-SMase is exposed to cellular Zn2+ during trafficking to lysosomes, in lysosomes, and/or during cell homogenization. In contrast, the pathway targeting S-SMase to secretion appears to be relatively sequestered from cellular pools of Zn2+; thus S-SMase requires exogeneous Zn2+ for full activity. This model provides important information for understanding the enzymology and regulation of L- and S-SMase and for exploring possible roles of ASM gene products in cell signaling and atherogenesis.


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
S. Uhlig and E. Gulbins
Sphingolipids in the Lungs
Am. J. Respir. Crit. Care Med., December 1, 2008; 178(11): 1100 - 1114.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Jin, F. Yi, F. Zhang, J. L. Poklis, and P.-L. Li
Lysosomal Targeting and Trafficking of Acid Sphingomyelinase to Lipid Raft Platforms in Coronary Endothelial Cells
Arterioscler. Thromb. Vasc. Biol., November 1, 2008; 28(11): 2056 - 2062.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. M. Devlin, A. R. Leventhal, G. Kuriakose, E. H. Schuchman, K. J. Williams, and I. Tabas
Acid Sphingomyelinase Promotes Lipoprotein Retention Within Early Atheromata and Accelerates Lesion Progression
Arterioscler. Thromb. Vasc. Biol., October 1, 2008; 28(10): 1723 - 1730.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
K. M. Argraves and W. S. Argraves
HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects
J. Lipid Res., November 1, 2007; 48(11): 2325 - 2333.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. H. Zeidan and Y. A. Hannun
Activation of Acid Sphingomyelinase by Protein Kinase C{delta}-mediated Phosphorylation
J. Biol. Chem., April 13, 2007; 282(15): 11549 - 11561.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
W. Doehner, A. C. Bunck, M. Rauchhaus, S. von Haehling, F. M. Brunkhorst, M. Cicoira, C. Tschope, P. Ponikowski, R. A. Claus, and S. D. Anker
Secretory sphingomyelinase is upregulated in chronic heart failure: a second messenger system of immune activation relates to body composition, muscular functional capacity, and peripheral blood flow
Eur. Heart J., April 1, 2007; 28(7): 821 - 828.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Charruyer, S. Grazide, C. Bezombes, S. Muller, G. Laurent, and J.-P. Jaffrezou
UV-C Light Induces Raft-associated Acid Sphingomyelinase and JNK Activation and Translocation Independently on a Nuclear Signal
J. Biol. Chem., May 13, 2005; 280(19): 19196 - 19204.
[Abstract] [Full Text] [PDF]


Home page
J Biomol ScreenHome page
R. J. Mintzer, K. C. Appell, A. Cole, A. Johns, R. Pagila, M. A. Polokoff, I. Tabas, R. M. Snider, and J. A. Meurer-Ogden
A Novel High-Throughput Screening Format to Identify Inhibitors of Secreted Acid Sphingomyelinase
J Biomol Screen, April 1, 2005; 10(3): 225 - 234.
[Abstract] [PDF]


Home page
Protein Sci.Home page
M. Seto, M. Whitlow, M. A. McCarrick, S. Srinivasan, Y. Zhu, R. Pagila, R. Mintzer, D. Light, A. Johns, and J. A. Meurer-Ogden
A model of the acid sphingomyelinase phosphoesterase domain based on its remote structural homolog purple acid phosphatase
Protein Sci., December 1, 2004; 13(12): 3172 - 3186.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Bezombes, S. Grazide, C. Garret, C. Fabre, A. Quillet-Mary, S. Muller, J.-P. Jaffrezou, and G. Laurent
Rituximab antiproliferative effect in B-lymphoma cells is associated with acid-sphingomyelinase activation in raft microdomains
Blood, August 15, 2004; 104(4): 1166 - 1173.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Flood, M. Gustafsson, R. E. Pitas, L. Arnaboldi, R. L. Walzem, and J. Boren
Molecular Mechanism for Changes in Proteoglycan Binding on Compositional Changes of the Core and the Surface of Low-Density Lipoprotein-Containing Human Apolipoprotein B100
Arterioscler. Thromb. Vasc. Biol., March 1, 2004; 24(3): 564 - 570.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
H. Qiu, T. Edmunds, J. Baker-Malcolm, K. P. Karey, S. Estes, C. Schwarz, H. Hughes, and S. M. Van Patten
Activation of Human Acid Sphingomyelinase through Modification or Deletion of C-terminal Cysteine
J. Biol. Chem., August 29, 2003; 278(35): 32744 - 32752.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
W. Drobnik, G. Liebisch, F.-X. Audebert, D. Frohlich, T. Gluck, P. Vogel, G. Rothe, and G. Schmitz
Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients
J. Lipid Res., April 1, 2003; 44(4): 754 - 761.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Grassme, V. Jendrossek, J. Bock, A. Riehle, and E. Gulbins
Ceramide-Rich Membrane Rafts Mediate CD40 Clustering
J. Immunol., January 1, 2002; 168(1): 298 - 307.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
N. UEDA, S. M. R. CAMARGO, X. HONG, A. G. BASNAKIAN, P. D. WALKER, and S. V. SHAH
Role of Ceramide Synthase in Oxidant Injury to Renal Tubular Epithelial Cells
J. Am. Soc. Nephrol., November 1, 2001; 12(11): 2384 - 2391.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
F. Paris, Z. Fuks, A. Kang, P. Capodieci, G. Juan, D. Ehleiter, A. Haimovitz-Friedman, C. Cordon-Cardo, and R. Kolesnick
Endothelial Apoptosis as the Primary Lesion Initiating Intestinal Radiation Damage in Mice
Science, July 13, 2001; 293(5528): 293 - 297.
[Abstract] [Full Text]


Home page
FASEB J.Home page
S. R. P. MIRANDA, X. HE, C. M. SIMONARO, S. GATT, A. DAGAN, R. J. DESNICK, and E. H. SCHUCHMAN
Infusion of recombinant human acid sphingomyelinase into Niemann-Pick disease mice leads to visceral, but not neurological, correction of the pathophysiology
FASEB J, October 1, 2000; 14(13): 1988 - 1995.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Renal Physiol.Home page
E. Gulbins, A. Jekle, K. Ferlinz, H. Grassme, and F. Lang
Physiology of apoptosis
Am J Physiol Renal Physiol, October 1, 2000; 279(4): F605 - F615.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
S. Marathe, S. R.P. Miranda, C. Devlin, A. Johns, G. Kuriakose, K. J. Williams, E. H. Schuchman, and I. Tabas
Creation of a mouse model for non-neurological (type B) Niemann-Pick disease by stable, low level expression of lysosomal sphingomyelinase in the absence of secretory sphingomyelinase: relationship between brain intra-lysosomal enzyme activity and central nervous system function
Hum. Mol. Genet., August 12, 2000; 9(13): 1967 - 1976.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M.-L. Wong, B. Xie, N. Beatini, P. Phu, S. Marathe, A. Johns, P. W. Gold, E. Hirsch, K. J. Williams, J. Licinio, et al.
Acute systemic inflammation up-regulates secretory sphingomyelinase in vivo: A possible link between inflammatory cytokines and atherogenesis
PNAS, July 5, 2000; (2000) 150098097.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
K. Bernardo, O. Krut, K. Wiegmann, D. Kreder, M. Micheli, R. Schafer, A. Sickman, W. E. Schmidt, J. M. Schroder, H. E. Meyer, et al.
Purification and Characterization of a Magnesium-dependent Neutral Sphingomyelinase from Bovine Brain
J. Biol. Chem., March 10, 2000; 275(11): 7641 - 7647.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Marathe, G. Kuriakose, K. J. Williams, and I. Tabas
Sphingomyelinase, an Enzyme Implicated in Atherogenesis, Is Present in Atherosclerotic Lesions and Binds to Specific Components of the Subendothelial Extracellular Matrix
Arterioscler. Thromb. Vasc. Biol., November 1, 1999; 19(11): 2648 - 2658.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Kirschnek, F. Paris, M. Weller, H. Grassme, K. Ferlinz, A. Riehle, Z. Fuks, R. Kolesnick, and E. Gulbins
CD95-mediated Apoptosis in Vivo Involves Acid Sphingomyelinase
J. Biol. Chem., August 25, 2000; 275(35): 27316 - 27323.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. W. Reagan Jr., M. L. Hubbert, and G. S. Shelness
Posttranslational Regulation of Acid Sphingomyelinase in Niemann-Pick Type C1 Fibroblasts and Free Cholesterol-enriched Chinese Hamster Ovary Cells
J. Biol. Chem., November 22, 2000; 275(48): 38104 - 38110.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M.-L. Wong, B. Xie, N. Beatini, P. Phu, S. Marathe, A. Johns, P. W. Gold, E. Hirsch, K. J. Williams, J. Licinio, et al.
Acute systemic inflammation up-regulates secretory sphingomyelinase in vivo: A possible link between inflammatory cytokines and atherogenesis
PNAS, July 18, 2000; 97(15): 8681 - 8686.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. Kleine, G. Liu, N. Leblanc, and R. L. Hebert
Bradykinin stimulates ceramide production by activating specific BK-B1 receptor in rat small artery
Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H175 - H183.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.